-
Get the latest information and research on osteoporosis.
-
Find treatment, guidance and advice on living with osteoporosis.
-
Share your experience and get involved. Joining the conversation is the first step to ending osteoporosis and broken bones.
Patient Champions of the National Osteoporosis Foundation Meet with Their Royal Highnesses The Duchess of Cornwall and The Prince of Wales to Discuss Osteoporosis During Official U.S. Visit
(Washington, DC) November 2, 2005 – Their Royal Highnesses The Duchess of Cornwall accompanied by The Prince of Wales will meet with the National Osteoporosis Foundation (NOF) and several of the Foundation’s patient champions onThursday, November 3, 2005 during a meeting at the National Institutes of Health. The meeting will focus on increasing awareness of osteoporosis, a disease which the U.S. Surgeon General has recognized as a growing public health threat in his landmark report released in 2004.
The Duchess serves as president of the National Osteoporosis Society (NOS) in the UK. As sister organizations, NOF and NOS are the leading voluntary health organizations in their respective countries dedicated solely to osteoporosis and bone health.
“Osteoporosis-related fractures occur in one in two women and one in four men over the age of 50 in the U.S. today, yet we know that this disabling and costly condition is largely preventable,” says Dr. Ethel Siris, President of NOF and Director of the Toni Stabile Center for the Prevention and Treatment of Osteoporosis at New York-Presbyterian Hospital/Columbia University Medical Center. “We appreciate Her Royal Highness The Duchess of Cornwall’s long-standing commitment to raising awareness of this disease and we look forward to meeting her.”
Established in 1984, NOF is working to make bone health a reality and a lifelong priority for all individuals through programs of awareness, public and health professional education, advocacy and research.
An estimated 44 million American men and women ages 50 and older either have or are at risk for the disease, according to NOF prevalence statistics. Osteoporosis, or porous bone, is a disease characterized by low bone mass and structural deterioration of bone tissue, leading to bone fragility and an increased susceptibility to fractures, especially of the hip, spine and wrist, although any bone can be affected.
The latest
Last week, a Food and Drug Administration (FDA) Panel voted that the risks of calcitonin salmon outweigh the benefits for the treatment of postmenopausal osteoporosis. The panel joined health authorities around the world in reviewing the drug’s safety after two recent studies showed slightly higher rates of cancer among patients taking calcitonin. The panel voted against continued use of the drug by a narrow majority, pointing out that it has not been found very effective in preventing bone fractures.
In today's Washington Post article "Calcium and Vitamin D findings show that caring for your bones can be compilicated," NOF's senior clinical director, Dr. Felicia Cosman helps clear up some of the confusion around the recent and conflicting research on calcium and vitamin D. She says: "It’s confusing, even for doctors. But there’s a common thread: None of the heart or kidney risks were associated with calcium from food."
CIRCA, the leading international buyer of fine jewelry, diamonds and watches, announced a new partnership with NOF at a Generations of Strength luncheon at the Friars Club in New York City on February 26. To kick-off the partnership, CIRCA’s Acting CEO Mary L. Forté presented NOF Executive Director and CEO Amy Porter with a check for $25,000, to support NOF’s mission.
Explore by tag
